Transplantation proceedings · 2026
Inflammatory Pseudotumor Due to Actinomycosis Simulating Post-Transplant Lymphoproliferative Disorder.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lizzetti-Mendoza Grecia, Waisberg Daniel Reis, Bayona-Alvarado Gabriel, Ozelame Ricardo, Ducatti Liliana, Arantes Rubens Macedo, Martino Rodrigo Bronze, Rocha-Santos Vinicius, Pinheiro Rafael Soares, Haddad Luciana Bertocco, Silva Maciana Santos, Tanigawa Ryan Yukimatsu, Rocha Manoel Souza, Song Alice Tung Wan, Andraus Wellington
Аннотация
INTRODUCTION: Hepatic actinomycosis is a rare infection caused by anaerobic, gram-positive Actinomyces bacteria. Liver involvement represents 5% of all actinomycosis cases and usually occurs secondary to intra-abdominal infections, spreading via the porto-mesenteric venous system. Clinical symptoms and imaging findings are typically heterogeneous and nonspecific, often mimicking malignant tumors, which makes diagnosis difficult and frequently one of exclusion. Immunosuppressed patients, including liver transplant recipients, have increased risk and the disease should be considered when a solitary or atypical hepatic mass is detected.
CASE REPORT: The case discussed involves a female patient who underwent living-donor liver transplantation and biliodigestive anastomosis in 2018 for cirrhosis secondary to hepatitis B virus infection. She developed chronic biliary stenosis managed with periodic exchanges of percutaneous transhepatic biliary drain. In 2024, she presented with catheter displacement and peri-drain bile leakage. An abdominal computed tomography scan revealed a 150 mL hepatic collection compatible with abscess. Percutaneous drainage and antibiotics were started, but poor clinical and radiologic response raised suspicion for post-transplant lymphoproliferative disorder. A guided liver biopsy ultimately identified Actinomyces sp., confirming hepatic actinomycosis. Treatment with intravenous ampicillin for 1 month led to major improvement and 90% lesion resolution. She was discharged on oral amoxicillin-clavulanate for additional 3 months, with outpatient follow-up demonstrating favorable clinical response.
CONCLUSION: Although uncommon, hepatic actinomycosis should be considered a possible cause of hepatic masses in liver transplant recipients. Management is mainly conservative with prolonged antibiotics and drainage may be used for refractory cases. Prognosis is generally positive when the condition is adequately treated.
CASE REPORT: The case discussed involves a female patient who underwent living-donor liver transplantation and biliodigestive anastomosis in 2018 for cirrhosis secondary to hepatitis B virus infection. She developed chronic biliary stenosis managed with periodic exchanges of percutaneous transhepatic biliary drain. In 2024, she presented with catheter displacement and peri-drain bile leakage. An abdominal computed tomography scan revealed a 150 mL hepatic collection compatible with abscess. Percutaneous drainage and antibiotics were started, but poor clinical and radiologic response raised suspicion for post-transplant lymphoproliferative disorder. A guided liver biopsy ultimately identified Actinomyces sp., confirming hepatic actinomycosis. Treatment with intravenous ampicillin for 1 month led to major improvement and 90% lesion resolution. She was discharged on oral amoxicillin-clavulanate for additional 3 months, with outpatient follow-up demonstrating favorable clinical response.
CONCLUSION: Although uncommon, hepatic actinomycosis should be considered a possible cause of hepatic masses in liver transplant recipients. Management is mainly conservative with prolonged antibiotics and drainage may be used for refractory cases. Prognosis is generally positive when the condition is adequately treated.